Epidemiology and etiology of Hodgkin's lymphoma

Annals of Oncology

Volumn 13, Issue SUPPL. 4, 2002, Pages 147-152

  Thomas, R K ^a   Re, D ^a   Zander, T ^a   Wolf, J ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENETIC DISORDER; GENETIC STABILITY; GERMINAL CENTER; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; MALE; MICROSATELLITE INSTABILITY; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; T LYMPHOCYTE; TH2 CELL; UPREGULATION; VIRUS EXPRESSION;

EID: 0036436037     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf652     Document Type: Article

References (75)

1. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Medico-Chirugical Trans 1832; 17: 68.
2. Parkin DM, Muir CS, Whelan S et al. Cancer Incidence in Five Continents, Vol. VI. Lyon: International Agency for Research on Cancer 1992.
3. Crowther D, Sutcliff SB, Bonadonna G. Hodgkin's disease in adults. In Peckham M, Pinedo HM, Veronesi U (eds): Oxford Textbook of Oncology, Vol. 2. New York, NY: Oxford University Press 1995; 1720-1725.
4. Mueller N. Hodgkin's disease. In Schnottenfeld D, Fraumeni J (eds): Cancer Epidemiology and Prevention, Vol. 2. New York, NY: Oxford University Press 1992; 877.
5. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the 'two-disease hypothesis'. Cancer Treat Rep 1982; 66: 689-695.
6. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease in the young. Int J Cancer 1977; 19: 595-604.
7. Wolf J, Diehl V. Is Hodgkin's disease an infectious disease? Ann Oncol 1994; 5 (Suppl. 1): 105-111.
8. Mueller N, Evans A, Harris NL et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320: 689-695.
9. Glaser SL, Lin RJ, Stewart SL et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375-382.
10. Zarate-Osorno A, Roman LN, Kingma DW et al. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75: 1360-1366.
11. Brousset P, Chittal S, Schlaifer D et al. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 1991; 77: 1781-1786.
12. Jox A, Wolf J, Diehl V. Hodgkin's disease biology: recent advances. Hematol Oncol 1997; 15: 165-171.
13. Staratschek-Jox A, Kotkowski S, Belge G et al. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells: no evidence for the persistence of integrated viral fragments in latent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. Am J Pathol 2000; 156: 209-216.
14. Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982; 49: 2197-2200.
15. Mack TM, Cozen W, Shibata DK et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332: 413-418.
16. Lindelof B, Eklund G. Analysis of hereditary component of cancer by use of a familial index by site. Lancet 2001; 358: 1696-1698.
17. Stein H, Hummel M. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies. Semin Hematol 1999; 36: 233-241.
18. Foss HD, Anagnostopoulos I, Araujo I et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005-4011.
19. Carbone A, Gloghini A, Gattei V et al. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 1997; 89: 3787-3794.
20. Pinkus GS, Pinkus JL, Langhoff E et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation? Am J Pathol 1997; 150: 543-562.
21. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999; 154: 1685-1691.
22. von Wasielewski R, Werner M, Fischer R et al. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997; 150: 793-803.
23. Kuppers R, Rajewsky K, Zhao M et al. Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962-10966.
24. Kuppers R, Rajewsky K. The origin of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998; 16: 471-493.
25. Wolf J, Kapp U, Bohlen H et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 3418-3428.
26. Kanzler H, Hansmann ML, Kapp U et al. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 1996; 87: 3429-3436.
27. Jox A, Zander T, Diehl V et al. Clonal relapse in Hodgkin's disease. N Engl J Med 1997; 337: 499.
28. Jox A, Zander T, Kornacker M et al. Detection of identical Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later. Ann Oncol l998; 9: 283-287.
29. Vockerodt M, Soares M, Kanzler H et al. Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. Blood 1998; 92: 2899-2907.
30. Muschen M, Rajewsky K, Brauninger A et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med 2000; 191: 387-394.
31. Seitz V, Hummel M, Marafioti T et al. Detection of clonal T-cell receptor γ-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin's disease. Blood 2000; 95: 3020-3024.
32. Braeuninger A, Kuppers R, Strickler JG et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin's disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci USA 1997; 94: 9337-9342.
33. Kanzler H, Kuppers R, Hansmann ML et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-1505.
34. Marafioti T, Hummel M, Foss HD et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-1450.
35. Jox A, Zander T, Kuppers R et al. Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells. Blood 1999; 93: 3964-3972.
36. Theil J, Laumen H, Marafioti T et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001; 97: 3191-3196.
37. Re D, Staratschek-Jox A, Holtick U et al. Deregulation of immunoglobulin gene transcription in the Hodgkin/Reed-Sternberg cell line L1236. Br J Haematol 2001; 115: 326-328.
38. Re D, Muschen M, Ahmadi T et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed-Sternberg cells. Cancer Res 2001; 61: 2080-2084.
39. Stein H, Marafioti T, Foss HD et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin's disease but not in lymphocyte predominant Hodgkin's disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501.
40. Torlakovic E, Tierens A, Dang HD et al. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 2001; 159: 1807-1814.
41. Henderson A, Calame K. Transcriptional regulation during B cell development. Annu Rev Immunol 1998; 16: 163-200.
42. Kube D, Holtick U, Vockerodt M et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001; 98: 762-770.
43. Skinnider BF, Elia AJ, Gascoyne RD et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002; 99: 618-626.
44. Bargou RC, Leng C, Krappmann D et al. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-4347.
45. Gires O, Zimber-Strobl U, Gonnella R et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997; 16: 6131-6140.
46. Hinz M, Loser P, Mathas S et al. Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001; 97: 2798-2807.
47. Emmerich F, Meiser M, Hummel M et al. Overexpression of IκBα without inhibition of NF-κB activity and mutations in the IkBa gene in Reed-Sternberg cells. Blood 1999; 94: 3129-3134.
48. Cabannes E, Khan G, Aillet F et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene 1999; 18: 3063-3070.
49. Jungnickel B, Staratschek-Jox A, Brauninger A et al. Clonal deleterious mutations in the IkBa gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395-402.
50. Fiumara P, Snell V, Li Y et al. Functional expression of receptor activator of nuclear factor κB in Hodgkin's disease cell lines. Blood 2001; 98: 2784-2790.
51. Kapp U, Yeh WC, Patterson B et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 1999; 189: 1939-1946.
52. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996; 381: 751-758.
53. Rothstein TL, Wang JK, Panka DJ et al. Protection against Fas-dependent Th1 mediated apoptosis by antigen receptor engagement in B-cells. Nature 1995; 374: 163-165.
54. Schattner E, Friedman SM. Fas expression and apoptosis in human B cells. Immunol Res 1996; 15: 246-257.
55. Re D, Hofmann A, Wolf J et al. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95. Exp Hematol 2000; 28: 31-35.
56. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456.
57. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-827.
58. Medema JP, Scaffidi C, Kischkel FC et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 2794-2804.
59. Muschen M, Re D, Brauninger A et al. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. Cancer Res 2000; 60: 5640-5643.
60. Chhanabhai M, Krajewski S, Krajewska M et al. Immunohistochemical analysis of interleukin-1β-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease. Blood 1997; 90: 2451-2455.
61. Thomas RK, Kallenborn A, Wickenhauser C et al. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Am J Pathol 2002; 160: 1521-1528.
62. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
63. Montesinos-Rongen M, Roers A, Kuppers R et al. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 1999; 94: 1755-1760.
64. Maggio EM, Stekelenburg E, Van den Berg A et al. TP53 gene mutations in Hodgkin's lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 2001; 94: 60-66.
65. Re D, Benenson L, Wickenhauser C et al. Proficient mismatch repair protein expression in Hodgkin and Reed-Sternberg cells. Int J Cancer 2002; 97: 205-210.
66. Falzetti D, Crescenzi B, Matteuci C et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999; 84: 298-305.
67. + Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86: 1464-1468.
68. Gravel S, Delsol G, Al Saati T. Single-cell analysis of the t(14;18)(q32;q2l) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 1998; 91: 2866-2874.
69. Weber-Matthiesen K, Deerberg-Wittram J, Rosenwald A et al. Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous inummophenotyping and interphase cytogenetics. Am J Pathol 1996; 149: 463-468.
70. Martín-Subero JI, Gesk S, Harder L et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin's lymphoma. Blood 2002; 99: 1474-1477.
71. + Hodgkin cells. Cancer Res 2000; 60: 549-552.
72. Hasse U, Tinguely M, Leibundgut EO et al. Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells. J Natl Cancer Inst 1999; 91: 1581-1583.
73. Poppema S, Potters M, Visser L et al. Immune escape mechanisms in Hodgkin's disease. Ann Oncol 1998; 9 (Suppl. 5): S21-S24.
74. Hsu SM, Lin J, Xie SS et al. Abundant expression of transforming growth factor-β1 and -β2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hum Pathol 1993; 24: 249-255.
75. Herbst H, Foss HD, Samol J et al. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 1996; 87: 2918-2929.